TrialJournal of human hypertension2015

Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension.

J Dingemanse et al.PubMed ↗Publisher ↗

No numbers read from the abstract.